IP Library Granted Patent US 7,056,699
Granted Patent B2
US 7,056,699 · App. 11/155,043 · Granted Jun 6, 2006

Lentiviral LTR-deleted vector

Assignee: Oxford Biomedia (UK) Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,056,699
App. No.
11/155,043
Granted
Jun 6, 2006
Kind
B2
Abstract

A vector capable of transducing non-dividing and/or slowly dividing cells is provided, wherein the vector is a lentiviral LTR-deleted vector. Also provided is a method for producing a protein of interest in a non-dividing or slowly dividing cell by transducing the cell with a lentiviral LTR-deleted vector and expressing the protein of interest in the cell. In addition, target cells containing the lentiviral LTR-deleted vector are provided.

Claims (13)

1. A lentiviral vector capable of transducing a non-dividing or slowly-dividing cell, said vector comprising a lentiviral LTR-deleted vector.

2. The lentiviral vector according to claim 1 , further comprising a nucleotide sequence encoding a protein of interest.

3. A target cell in vitro comprising the lentiviral vector of claim 1 .

4. A method for producing a protein of interest in a non-dividing or slowly-dividing cell, comprising the steps of:

a) transducing the cell with the lentiviral vector according to claim 2 ; and

b) expressing the protein of interest in the cell.

5. A target cell in vitro comprising the lentiviral vector of claim 2 .

6. A method of performing gene delivery on a target cell comprising the steps of:

a) transducing the target cell with the lentiviral vector according to claim 2 ; and

b) delivering the nucleotide sequence to the target cell.

7. The method according to claim 4 , wherein the non-dividing cell is a neuron.

8. A lentiviral LTR-deleted vector.

9. The lentiviral LTR-deleted vector according to claim 8 , further comprising a nucleotide sequence of interest.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 11, 2017
From: OBERLAND CAPITAL SA LLC
To: OXFORD BIOMEDICA (UK) LIMITED
Reel/Frame 042975/0446 →
SECURITY INTEREST Recorded Jun 22, 2015
From: OXFORD BIOMEDICA (UK) LIMITED
To: OBERLAND CAPITAL SA LLC
Reel/Frame 035993/0501 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2006
From: KINGSMAN, ALAN J.; KINGSMAN, SUSAN M.
To: OXFORD BIOMEDICA (UK) LIMITED
Reel/Frame 018040/0400 →
Priority Claims (1)
GB 9622500.8 · Oct 29, 1996 · national
Continuity (3)
Continuation 1032461600 · Dec 20, 2002
Continuation In Part 0925483200
Related Publication 20050238629A1 · Oct 27, 2005